Page 36 - Mobile Opera News Today

Several cases of acute, severe hepatitis in children in Alabama provided additional evidence in support of a possible link between this illness and adenovirus, according to a report published in Morbidity and Mortality Weekly Report.“This cluster, along with recently identified possible cases in Europe, suggests that adenovirus should be considered in the differential diagnosis of acute

Orphalan announced FDA approval of Cuvrior for the treatment of adults with stable Wilson’s disease who are de-coppered and tolerant to penicillamine, according to a company press release.

Strive Health is expanding its relationship with Nephrology Associates of Northern Illinois and Indiana to help manage up to 20,000 patients with kidney disease, according to a company press release.

The rate of vertical hepatitis C transmission is nearly 25% higher than commonly assumed, according to a reanalysis of data from more than 1,700 children born to mothers infected with the virus.

Supernus Pharmaceuticals announced FDA approval of viloxazine extended-release capsules to treat ADHD in patients aged 18 years and older.The FDA has now given its consent to viloxazine (Qelbree, Supernus), a once-per-day oral nonstimulant for the treatment of ADHD, starting with children aged 6 years, as well as adolescents and adults, a company press release stated.

Researchers estimated that more than 200 million people globally suffer from long-term effects of COVID-19, according to a recent study. “There has been substantial confusion and heterogeneity about what fraction of COVID-19-diagnosed patients struggle with post-COVID conditions after the acute symptomatic phase of infection is over. There has been substantial ambiguity in the definition of

A novel catheter-based cardioneural ablation procedure reduced symptoms of vasovagal syncope by as much as 80% for patients with symptoms despite medical intervention and behavioral modification who did not desire permanent pacing.Early published reports of cardioneural ablation have shown promise for the relief of autonomically mediated bradycardia; however, cases are typically performed on a

In patients with recently diagnosed atrial fibrillation and a high comorbidity burden, early rhythm control therapy markedly reduced CV death, stroke or hospitalization for HF or ACS, according to new data from the EAST-AFNET 4 trial.However, early rhythm control was not effective in patients with fewer CV comorbidities compared with usual care, and therapy-related bradycardia and drug toxicity

Among patients hospitalized with COVID-19, dapagliflozin was well tolerated and did not increase risk of AKI in patients, according to data published in the Clinical Journal of the American Society of Nephrology.Further, dapagliflozin was well tolerated among patients with an eGFR below 60 mL/minute per 1.73² and among those with an eGFR above 60 mL/minute per 1.73².

Adults with type 2 diabetes who drink coffee had less decline in kidney function over time compared with non-coffee drinkers, according to study findings published in the Journal of Diabetes Investigation. In an analysis of data from more than 3,000 adults with type 2 diabetes in Japan, coffee drinkers had a lower risk for estimated glomerular filtration rate decline and less annual change in